Fierce Pharma

Halozyme stymies subcutaneous Keytruda launch in select European countries as Merck vows to fight patent claims

After facing a setback in Germany late last year, Merck & Co.’s European marketing plans for its below-the-skin Keytruda SC are growing more complicated. | After facing a setback in Germany late last ...
Fierce Pharma

New API Innovation Center index spotlights supply chain stress points

The National Fragility Index, launched by the API Innovation Center, warns that more than 550 million prescriptions filled in the U.S. in 2023 were for drugs ranked as having high or severe ...
Fierce Pharma

How drugmakers are tapping into the GLP-1 frenzy's unprecedented 'consumer overlay'

The successes of the GLP-1 class for chronic weight management “introduced consumer overlay over a historically physician-driven therapeutic area,” Pothier explained, noting that despite the potency ...
Fierce Pharma

Catalent wins access to Iro and launches next-gen development platform

Catalent is vying for a stronger foothold in next-gen drug development, and it's betting on developer's need for speed. | ...
Fierce Pharma

Scaling psychedelics comes with uncertainty ‘baked into the sauce’

The possibility of psychedelic therapies for PTSD or treatment-resistant depression in the U.S. has never been greater. But even as the industry inches closer to an FDA go-ahead, the realities of ...
Fierce Pharma

Noom puts a spooky voice to the haunting threat of weight regain for GLP-1 users in new spot

The bright, sunny shots of Noom’s chief wellness ambassador Rebel Wilson seen in the debut of the digital health company’s ...
Fierce Pharma

ViiV girds data package for Cabenuva in competitive HIV treatment market

As competition in both the HIV treatment and prevention fields continues to mount, GSK’s ViiV Healthcare is looking to expand ...
Fierce Pharma

BD commits $19B amid US onshoring push, with $3B earmarked for manufacturing growth

Through its pledge, BD will invest $19 billion in the U.S. over the span of “several years,” with the outlay taking the form of capital, operational and supply chain investments, the company said in ...
Fierce Pharma

Novo flags FDA hemophilia review extension tied to manufacturing site corrections

Already boasting a positive recommendation overseas, Novo’s hemophilia A newcomer Frehemgo will have to wait a while longer ...
Fierce Pharma

BridgeBio taps Hip Hop Public Health and others up to put a new beat on ATTR-CM awareness

Attruby maker BridgeBio is re-upping its “Don’t Pass on Your Heart Health” campaign with a fresh new beat.  | BridgeBio's YouTube awareness push to lead up to World Amyloidosis Day features a ...
Fierce Pharma

AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy

AbbVie and Genmab are touting a much-anticipated first-line win for | Epkinly plus R-CHOP cut the risk of progression or death by 51% compared with R-CHOP alone in newly diagnosed DLBCL, setting up a ...
Fierce Pharma

Bayer doubles down on US with $2.2B Ohio manufacturing project

Following a spate of large-scale pharma investments in the U.S. last year, German conglomerate Bayer is advancing its own plans to expand in America, in a move the company is framing as the ...